Predictive Oncology
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Predictive Oncology's past years’ income statements indicate that its last revenue has increased compared to the previous period by 18% to $1,780,093. The net income raised on -$13,983,967 and profit margin reached -786%. Total operating expenses were $15,129,264.
Profit Margin
| 2014 | 951.55K | -6.83M | -718.14% |
|---|---|---|---|
| 2015 | 654.35K | -4.79M | -732.1% |
| 2016 | 456.49K | -6.52M | -1429.59% |
| 2017 | 654.83K | -7.74M | -1182.98% |
| 2018 | 1.41M | -10.08M | -714.51% |
| 2019 | 1.41M | -27.55M | -1952.17% |
| 2020 | 1.25M | -37.70M | -3010.66% |
| 2021 | 1.42M | -19.65M | -1383.65% |
| 2022 | 1.50M | -36.20M | -2405.08% |
| 2023 | 1.78M | -13.98M | -785.58% |
POAI Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 1.78M | 1.50M | 1.42M | 1.25M | 1.41M | 1.41M | 654.83K | 456.49K | 654.35K | 951.55K |
Cost of revenue | 634.79K | 505.10K | 487.02K | 447.19K | 531.81K | 415.76K | 148.04K | 181.62K | 303.98K | 385.32K |
Gross profit | 1.14M | 1.00M | 933.65K | 805.08K | 879.75K | 995.89K | 506.79K | 274.87K | 350.37K | 566.23K |
Operating exp. | ||||||||||
Research and development | 188.30K | 320.32K | 315.85K | 2.35M | 2.96M | 1.86M | 289K | 406K | 261K | 394K |
Selling and marketing | 1.51M | 1.35M | 774.53K | 584.93K | 1.91M | 2.36M | 1.00M | 467.97K | 503.98K | 1.17M |
Total operating expenses | 15.12M | 16.26M | 14.40M | 13.28M | 14.65M | 8.85M | 8.25M | 6.80M | 4.75M | 7.03M |
Operating income | -13.92M | -15.26M | -13.47M | -666.26K | -13.77M | -7.86M | -7.74M | -6.52M | -4.39M | -6.46M |
Other income (expenses), net | -62.63K | -10.46M | -6.84M | -13.40M | -5.61M | -2.22M | 50.50K | -3 | -390.88K | -366.12K |
Income before tax | -13.98M | -25.73M | -20.31M | -25.88M | -19.39M | -10.08M | -7.74M | -6.52M | -4.79M | -6.83M |
Income tax expense | 0 | 10.46M | -661.65K | 11.81M | 8.16M | -2.22M | 50.50K | 0 | 0 | 377.71K |
Net income | -13.98M | -36.20M | -19.65M | -37.70M | -27.55M | -10.08M | -7.74M | -6.52M | -4.79M | -6.83M |
Earnings per share | ||||||||||
Basic EPS | -3.48 | -9.92 | -7.16 | -63.1 | -192.02 | -157.4 | -243.5 | -462.31 | -4.60K | -11.05K |
Diluted EPS | -3.48 | -9.92 | -7.16 | -63.1 | -192.02 | -157.4 | -243.5 | -462.31 | -4.60K | -11.05K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |